Novel activators and small-molecule inhibitors of STAT3 in cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel activators and small-molecule inhibitors of STAT3 in cancer

Published:2019-10 Issue: Volume:49 Page:10-22
ISSN:1359-6101
Container-title:Cytokine & Growth Factor Reviews
language:en
Short-container-title:Cytokine & Growth Factor Reviews

Author:

Yang Lehe,Lin Shichong,Xu Lingyuan,Lin Jiayuh,Zhao Chengguang,Huang Xiaoying

Funder

Medical Scientific Research Fund of Zhejiang Province

Wenzhou science and technology project

Science and Technology Innovation Activity Plan for College Students of Zhejiang Province

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Endocrinology, Diabetes and Metabolism

Reference125 articles.

1. Targeting the IL-6/JAK/STAT3 signalling axis in cancer;Johnson;Nat. Rev. Clin. Oncol.,2018

2. STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review;Qin;J. Exp. Clin. Cancer Res.,2019

3. FDA-approved small-molecule kinase inhibitors;Wu;Trends Pharmacol. Sci.,2015

4. Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors;Lee;Redox Biol.,2018

5. Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?;Beebe;Pharmacol. Ther.,2018

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SVIL promotes ovarian cancer progression and epithelial-mesenchymal transition under hypoxic conditions through the TGF-β/Smad pathway;Gynecologic Oncology;2024-11

2. Unveiling the potential of isatin-grafted phenyl-1,2,3-triazole derivatives as dual VEGFR-2/STAT-3 inhibitors: Design, synthesis and biological assessments;Bioorganic Chemistry;2024-10

3. Isotoosendanin exerts anti-tumor effects in NSCLC by enhancing the stability of SHP-2 and inhibiting the JAK/STAT3 pathway;Phytomedicine;2024-09

4. Feasibility of the inhibitor development for cancer: A systematic approach for drug design;PLOS ONE;2024-08-22

5. Pyrimidine compounds BY4003 and BY4008 inhibit glioblastoma cells growth via modulating JAK3/STAT3 signaling pathway;Neurotherapeutics;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3